These disclosures were last updated on Feb. He has also received grants or research support from Gilead, Merck, and ViiV. Wohl has worked as a consultant or independent contributor for Gilead Sciences, Janssen Pharmaceuticals, Merck & Co., and ViiV Healthcare. Wohl maintains a large HIV continuity clinic at UNC. In addition to his research and administrative activities, Dr. He is site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AIDS Education and Training Center (AETC), and co-director of HIV services for the North Carolina state prison system. Wohl led UNC clinical research efforts to test interventions for Ebola Virus Disease in Liberia and now directs a clinical cohort of Ebola survivors. David Alain Wohl, M.D., is a professor of medicine in the Division of Infectious Diseases at the University of North Carolina (UNC). Department of Health and Human Services Antiretroviral Guidelines Panel.Īs part of the response to the 2013-2016 Ebola outbreak in West Africa, Dr. AIDS Clinical Trials Group and HIV Prevention Trials Network and served two terms as a member of the U.S. He is also active in investigations focused on populations vulnerable to HIV, such as the incarcerated.

Wohl's research aims to optimize the treatment of HIV, including identifying the most effective therapeutic approaches and minimizing the adverse effects of therapy. In 2014, he became co-director of the UNC-Duke Clinical RM Ebola Response Consortium.ĭr. He has indicated that he accepts telehealth appointments. He is affiliated with medical facilities such as Jefferson Bucks Hospital and Jefferson Frankford Hospital. David Alain Wohl, M.D., is a professor of medicine in the Division of Infectious Diseases at the University of North Carolina (UNC). Allan Wohl, DO is a Family Medicine Specialist in Philadelphia, PA.

Dr. elyana wohl